Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center

Diagn Microbiol Infect Dis. 1997 Nov;29(3):133-8. doi: 10.1016/s0732-8893(97)81802-0.

Abstract

A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip(r)) Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870 E. coli strains isolated during this period, 257 cip(r)-E. coli were recovered from 257 patients. The majority (96%) of these resistant strains were isolated from the urine samples. One hundred and twenty strains of cip(r)-E. coli were also resistant to four other fluoroquinolones. MICs ranging from 64 to 512 micrograms/mL were observed in 75% of the strains and > or = 1028 micrograms/mL in 6.4% of the strains. Resistance to ciprofloxacin was due to possible mutations in topoisomerase gyrA.

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Bacteriuria / drug therapy
  • Bacteriuria / epidemiology
  • Bacteriuria / microbiology
  • Ciprofloxacin / pharmacology*
  • DNA Gyrase
  • DNA Topoisomerases, Type II / genetics
  • Drug Resistance, Microbial
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology*
  • Genes, Bacterial
  • Humans
  • Los Angeles / epidemiology
  • Microbial Sensitivity Tests
  • Mutation
  • Rehabilitation Centers
  • Retrospective Studies
  • Time Factors

Substances

  • Anti-Infective Agents
  • Ciprofloxacin
  • DNA Gyrase
  • DNA Topoisomerases, Type II